Search research articles
Contact Us
Filters
Showing results (241-250 of 253) with videos related to
Page
of 26
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 24, 2020
Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies
Betty B Yao, Linda M Fredrick, Gretja Schnell, et al.
British Journal of Pharmacology
|
November 13, 2007
In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models
B B Yao, G C Hsieh, J M Frost, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery
|
March 16, 2023
[Observational study on perioperative outcomes of pelvic exenteration]
H Yuan, B Yao, J T Li, et al.
British Journal of Pharmacology
|
October 30, 2007
Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI
C-L Chin, A E Tovcimak, V P Hradil, et al.
Hepatology Communications
|
November 10, 2018
Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4
Daniel H Leung, Stefan Wirth, Betty B Yao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 4, 2025
Peri-operative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small cell lung cancer: final analysis of the randomized RATIONALE-315 trial
C Wang, W Wang, H Liu, et al.
British Journal of Pharmacology
|
May 6, 2009
In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory properties
M I Strakhova, C A Cuff, A M Manelli, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 22, 2008
Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging
Betty B Yao, Gin Hsieh, Anthony V Daza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2019
Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial
S Delaloge, D Cella, Y Ye, et al.
Physical Review Letters
|
April 21, 2023
Octahedral Distortion and Displacement-Type Ferroelectricity with Switchable Photovoltaic Effect in a 3d^{3}-Electron Perovskite System
B W Zhou, J Zhang, X B Ye, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 253) with videos related to
Sort By:
Page
of 26
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 24, 2020
Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies
Betty B Yao, Linda M Fredrick, Gretja Schnell, et al.
British Journal of Pharmacology
|
November 13, 2007
In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models
B B Yao, G C Hsieh, J M Frost, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery
|
March 16, 2023
[Observational study on perioperative outcomes of pelvic exenteration]
H Yuan, B Yao, J T Li, et al.
British Journal of Pharmacology
|
October 30, 2007
Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI
C-L Chin, A E Tovcimak, V P Hradil, et al.
Hepatology Communications
|
November 10, 2018
Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4
Daniel H Leung, Stefan Wirth, Betty B Yao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 4, 2025
Peri-operative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small cell lung cancer: final analysis of the randomized RATIONALE-315 trial
C Wang, W Wang, H Liu, et al.
British Journal of Pharmacology
|
May 6, 2009
In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory properties
M I Strakhova, C A Cuff, A M Manelli, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 22, 2008
Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging
Betty B Yao, Gin Hsieh, Anthony V Daza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2019
Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial
S Delaloge, D Cella, Y Ye, et al.
Physical Review Letters
|
April 21, 2023
Octahedral Distortion and Displacement-Type Ferroelectricity with Switchable Photovoltaic Effect in a 3d^{3}-Electron Perovskite System
B W Zhou, J Zhang, X B Ye, et al.
Page
of 26